Frontiers in neurology · 2025
Hemiplegic shoulder pain, a combined approach with suprascapular nerve block and intra-articular corticosteroid injections: a case series.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gahier Matthieu, Lecler Andy, Gadbled Guillaume, Arnolfo Paul, Gross Raphael
Аннотация
BACKGROUND: Hemiplegic shoulder pain (HSP) is a prevalent and disabling condition affecting patients after stroke or traumatic brain injury. There is currently no consensus regarding infiltrative strategies. A combined approach, involving suprascapular nerve block and intra-articular corticosteroid injection, has been proposed for HSP and capsulitis, yet evidence remains limited.
OBJECTIVE: This study presents the results (efficacy and safety) of this combined approach to alleviate pain and improve passive range of motion (PROM).
METHODS: A retrospective, multicenter observational study (36 patients).
RESULTS: At 1 month, the mean pain intensity (visual analogue scale VAS) significantly decreased from 6.5 ± 1.5 at baseline to 1.9 ± 2.1, and PROM showed significant improvement across all three planes (mean PROM gains: 28.4° in abduction, 29.2° in flexion, and 13.4° in external rotation). The benefits were largely maintained at 3 months, and no serious complications were observed (one vasovagal episode).
CONCLUSION: The combined approach is a clinically feasible, safe, and effective method for treating HSP in PRM settings.
OBJECTIVE: This study presents the results (efficacy and safety) of this combined approach to alleviate pain and improve passive range of motion (PROM).
METHODS: A retrospective, multicenter observational study (36 patients).
RESULTS: At 1 month, the mean pain intensity (visual analogue scale VAS) significantly decreased from 6.5 ± 1.5 at baseline to 1.9 ± 2.1, and PROM showed significant improvement across all three planes (mean PROM gains: 28.4° in abduction, 29.2° in flexion, and 13.4° in external rotation). The benefits were largely maintained at 3 months, and no serious complications were observed (one vasovagal episode).
CONCLUSION: The combined approach is a clinically feasible, safe, and effective method for treating HSP in PRM settings.